Knoxville, Tennessee-based, ChoiceSpine, LP has acquired Baxano Surgical Inc.’s VEO Lateral Access & Interbody Fusion System.
ChoiceSpine Buys Baxano’s VEO Lateral Fusion System
1 min read Premium comments
Secondary
The principals of ChoiceSpine, Marty Altshuler and Rick Henson, said they look forward to building relationships with previous VEO users and this provides a great opportunity to grow their Western footprint. “By adding a lateral system to our product offerings, as well as launching 4 new products in 2015, we can easily say that we are moving forward in the spinal marketplace.”
Baxano filed for Chapter 11 Bankruptcy late in 2014 and put its assets up for auction.
Baxano’s major assets included the AxiaLIF family of products for single and two level lower lumbar fusion, the VEO lateral access and interbody fusion system featuring the REVEAL retractor, the iO-Flex system, a set of flexible instruments used by surgeons during spinal decompression procedures, the iO-Tome instrument, which removes the facet joints and Avance, an MIS pedicle screw system used in lumbar fusion procedures.
No price was noted for the VEO system in the February 2, 2015 ChoiceSpine press release. In August and September 2014, ChoiceSpine announced FDA 510(k) clearance for its Lancer pedicle screw system and the Thunderbolt minimally invasive pedicle screw system. The company, which acquired Orthotec, was founded in 2006.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.